Nutrien (NYSE:NTR) Research Coverage Started at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Nutrien (NYSE:NTR) in a research report report published on Thursday, MarketBeat Ratings reports. The brokerage issued a sell rating and a $53.00 price objective on the stock.

NTR has been the topic of several other research reports. Mizuho upped their price objective on shares of Nutrien from $52.00 to $55.00 and gave the stock a “neutral” rating in a report on Thursday, February 20th. Royal Bank of Canada reiterated an “outperform” rating and set a $60.00 price target on shares of Nutrien in a research note on Monday, February 24th. Oppenheimer began coverage on Nutrien in a research note on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price objective for the company. Wells Fargo & Company raised their target price on Nutrien from $53.00 to $56.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Finally, Scotiabank upped their price target on Nutrien from $60.00 to $62.00 and gave the stock a “sector outperform” rating in a report on Monday, February 24th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $60.13.

Nutrien Price Performance

Shares of NYSE NTR opened at $50.82 on Thursday. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The firm’s 50-day moving average price is $51.26 and its 200-day moving average price is $48.68. The firm has a market capitalization of $24.86 billion, a P/E ratio of 37.09, a P/E/G ratio of 1.19 and a beta of 0.81. Nutrien has a 1-year low of $43.70 and a 1-year high of $60.87.

Nutrien (NYSE:NTR) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.09). The firm had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. Equities research analysts anticipate that Nutrien will post 3.72 earnings per share for the current fiscal year.

Nutrien Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be issued a $0.545 dividend. The ex-dividend date is Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a dividend yield of 4.29%. Nutrien’s dividend payout ratio (DPR) is presently 159.12%.

Hedge Funds Weigh In On Nutrien

Several institutional investors and hedge funds have recently bought and sold shares of the company. Lansforsakringar Fondforvaltning AB publ purchased a new position in shares of Nutrien during the 4th quarter valued at $4,952,000. PKO Investment Management Joint Stock Co purchased a new stake in Nutrien during the fourth quarter valued at about $712,000. Wealthedge Investment Advisors LLC bought a new position in Nutrien during the fourth quarter worth about $1,508,000. Probity Advisors Inc. increased its stake in shares of Nutrien by 16.0% in the fourth quarter. Probity Advisors Inc. now owns 25,739 shares of the company’s stock worth $1,152,000 after purchasing an additional 3,558 shares in the last quarter. Finally, Comprehensive Money Management Services LLC bought a new stake in shares of Nutrien in the fourth quarter valued at approximately $224,000. 63.10% of the stock is owned by institutional investors.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.